文献速递慢阻肺

高频气道振荡联合吸气肌训练对COPD呼吸困难的影响:TIDe随机对照试验

Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD.
PubMed 文献 · Thorax · 2021-10-27

这项双盲随机假对照试验纳入104例有症状的COPD患者,比较高频气道振荡(HFAO)装置与假装置每日三次、持续8周的疗效。HFAO组最大吸气压力较假组显著改善(5.26,95%CI 0.34至10.19,p=0.05)。

要点

  • HFAO装置8周未显著改善COPD患者CRQ-D呼吸困难评分。
  • 两组CRQ-D均随时间有有意义的改善,提示存在非特异性效应。
  • HFAO组最大吸气压力较假组显著改善,但组间差异处于临界水平。

核心结论

  • HFAO装置与假装置在改善COPD患者CRQ-D所测呼吸困难方面无统计学差异。
  • HFAO组最大吸气压力较假组显著改善(5.26,95%CI 0.34至10.19,p=0.05),但需谨慎解读。

研究设计与样本

  • 双盲、随机、假对照试验,招募有症状的COPD患者。
  • 患者随机接受HFAO装置(Aerosure)或假装置,每日三次,持续8周。
  • 共104例参与者(68%为男性,平均(SD)年龄69.75岁(7.41),FEV1占预计值百分比48.22%(18.75)),96例完成。
  • 主要结局为慢性呼吸问卷呼吸困难维度(CRQ-D);预设亚组分析包括呼吸肌无力、痰液过多和频繁急性加重者。
  • 试验注册号ISRCTN45695543。

主要发现

  • 两组CRQ-D随时间均有有意义的改善:HFAO组平均(SD)0.45(0.78),p<0.01;假组0.73(1.09),p<0.01。
  • HFAO组最大吸气压力较假组显著改善(5.26,95%CI 0.34至10.19,p=0.05)。
  • 亚组分析中观察到相似的模式。

临床怎么用

  • 对于有症状的COPD患者,HFAO装置不应以改善呼吸困难为主要目的常规推荐。
  • HFAO对最大吸气压力的改善处于临界水平,临床意义需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterised by symptomatic dyspnoea and reduced exercise tolerance, in part as a result muscle weakness, for which inspiratory muscle training (IMT) may be useful. Excess mucus hypersecretion commonly coexists in COPD and may lead to reduce ventilation, further impacting on breathlessness. Devices for sputum clearance may be employed to aid mucus expectoration. This trial aimed to explore the effectiveness of a combined IMT and high-frequency airway oscillating (HFAO) device in the management of dyspnoea. METHODS: This was a double-blinded, randomised sham-controlled trial which recruited symptomatic patients with COPD. Patients were randomised to either a HFAO device (Aerosure) or sham device for 8 weeks, three times a day. The primary outcome was the Chronic Respiratory Questionnaire dyspnoea (CRQ-D) domain. Pre-specified subgroup analyses were performed including those with respiratory muscle weakness, excessive sputum and frequent exacerbators. RESULTS: 104 participants (68% men, mean (SD) age 69.75 years (7.41), forced expiratory volume in 1 s per cent predicted 48.22% (18.75)) were recruited to this study with 96 participants completing. No difference in CRQ-D was seen between groups (0·28, 95% CI -0.19 to 0.75, p=0.24), though meaningful improvements were seen over time in both groups (mean (SD) HFAO 0.45 (0.78), p<0.01; sham 0.73 (1.09), p<0.01). Maximal inspiratory pressure significantly improved in the HFAO group over sham (5.26, 95% CI 0.34 to 10.19, p=0.05). Similar patterns were seen in the subgroup analysis. CONCLUSION: There were no statistical differences between the HFAO and the sham group in improving dyspnoea measured by the CRQ-D. TRIAL REGISTRATION NUMBER: ISRCTN45695543.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Daynes E, Greening N, Singh SJ, et al. Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD. Thorax. 2021. PMID: 34706980. doi:10.1136/thoraxjnl-2021-217072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。